Cargando…

Early Intervention and a Direction of Novel Therapeutics for the Improvement of Functional Outcomes in Schizophrenia: A Selective Review

BACKGROUND: A recent review reported that the median proportion of patients recovering from schizophrenia was 13.5% and that this did not change over time. Various factors including the duration of untreated psychosis, cognitive impairment, negative symptoms, and morphological changes in the brain i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurachi, Masayoshi, Takahashi, Tsutomu, Sumiyoshi, Tomiki, Uehara, Takashi, Suzuki, Michio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826072/ https://www.ncbi.nlm.nih.gov/pubmed/29515467 http://dx.doi.org/10.3389/fpsyt.2018.00039

Ejemplares similares

Analysis of polyunsaturated fatty acids in antipsychotic-free individuals with at-risk mental state and patients with first-episode schizophrenia
por: Le, Anh Thi Phuong, et al.
Publicado: (2023)

Apocynin-Tandospirone Derivatives Suppress Methamphetamine-Induced Hyperlocomotion in Rats with Neonatal Exposure to Dizocilpine
por: Uehara, Takashi, et al.
Publicado: (2022)

Electrophysiological Evidence in Schizophrenia in Relation to Treatment Response
por: Sueyoshi, Kazuki, et al.
Publicado: (2018)

New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function
por: Jeon, Won Je, et al.
Publicado: (2015)

Transcranial Direct Current Stimulation on the Left Superior Temporal Sulcus Improves Social Cognition in Schizophrenia: An Open-Label Study
por: Yamada, Yuji, et al.
Publicado: (2022)

Effect of Transcranial Direct Current Stimulation on Functional Capacity in Schizophrenia: A Study Protocol for a Randomized Controlled Trial
por: Narita, Zui, et al.
Publicado: (2017)

Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
por: Takeda, Kazuyoshi, et al.
Publicado: (2018)

Possible Facilitative Effects of Repeated Anodal Transcranial Direct Current Stimulation on Functional Outcome 1 Month Later in Schizophrenia: An Open Trial
por: Narita, Zui, et al.
Publicado: (2017)

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2019)

Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)

Electrode montage for transcranial direct current stimulation governs its effect on symptoms and functionality in schizophrenia
por: Yamada, Yuji, et al.
Publicado: (2023)

Does Sleep Improve Memory Organization?
por: Takeuchi, Masashi, et al.
Publicado: (2014)

T-817MA, but Not Haloperidol and Risperidone, Restores Parvalbumin-Positive γ-Aminobutyric Acid Neurons in the Prefrontal Cortex and Hippocampus of Rats Transiently Exposed to MK-801 at the Neonatal Period
por: Uehara, Takashi, et al.
Publicado: (2012)

Semantic Memory Organization in Japanese Patients With Schizophrenia Examined With Category Fluency
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2019)

A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient
por: Ohi, Kazutaka, et al.
Publicado: (2017)

Tandospirone, a 5-HT(1A) partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the therapeutics of cognitive impairment of schizophrenia
por: Uehara, Takashi, et al.
Publicado: (2014)

LORETA Current Source Density for Duration Mismatch Negativity and Neuropsychological Assessment in Early Schizophrenia
por: Miyanishi, Tomohiro, et al.
Publicado: (2013)

Social Cognition Deficits as a Target of Early Intervention for Psychoses: A Systematic Review
por: Yamada, Yuji, et al.
Publicado: (2019)

Increased brain gyrification and subsequent relapse in patients with first-episode schizophrenia
por: Sasabayashi, Daiki, et al.
Publicado: (2022)

Different Heschl’s Gyrus Duplication Patterns in Deficit and Non-deficit Subtypes of Schizophrenia
por: Takahashi, Tsutomu, et al.
Publicado: (2022)

Associations between daily living skills, cognition, and real-world functioning across stages of schizophrenia; a study with the Schizophrenia Cognition Rating Scale Japanese version
por: Higuchi, Yuko, et al.
Publicado: (2017)

Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
por: Omachi, Yoshie, et al.
Publicado: (2018)

Editorial: Cognitive Enhancement in Psychiatric Disorders
por: Sumiyoshi, Tomiki, et al.
Publicado: (2019)

Gray Matter Changes in the Insular Cortex During the Course of the Schizophrenia Spectrum
por: Takahashi, Tsutomu, et al.
Publicado: (2020)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Nakajima, Suguru, et al.
Publicado: (2021)

Prolonged P300 Latency in Antipsychotic-Free Subjects with At-Risk Mental States Who Later Developed Schizophrenia
por: Higuchi, Yuko, et al.
Publicado: (2021)

Are attention-deficit/hyperactivity disorder symptoms associated with negative health outcomes in individuals with psychotic experiences? Findings from a cross-sectional study in Japan
por: Stickley, Andrew, et al.
Publicado: (2023)

Gross anatomical features of the insular cortex in schizophrenia and schizotypal personality disorder: Potential relationships with vulnerability, illness stages, and clinical subtypes
por: Takahashi, Tsutomu, et al.
Publicado: (2022)

Pituitary Volume and Socio-Cognitive Functions in Individuals at Risk of Psychosis and Patients With Schizophrenia
por: Takahashi, Tsutomu, et al.
Publicado: (2018)

Reduced Hippocampal Subfield Volume in Schizophrenia and Clinical High-Risk State for Psychosis
por: Sasabayashi, Daiki, et al.
Publicado: (2021)

Psychoneurobiology Research and Personalized Treatment of Schizophrenia
por: Sumiyoshi, Tomiki
Publicado: (2021)

Gray Matter Changes in Subjects at High Risk for Developing Psychosis and First-Episode Schizophrenia: A Voxel-Based Structural MRI Study
por: Nakamura, Kazue, et al.
Publicado: (2013)

Mismatch Negativity and P3a/Reorienting Complex in Subjects with Schizophrenia or At-Risk Mental State
por: Higuchi, Yuko, et al.
Publicado: (2014)

Anatomical variations in the insular cortex in individuals at a clinical high-risk state for psychosis and patients with schizophrenia
por: Takahashi, Tsutomu, et al.
Publicado: (2023)

Development of the Positive Emotions Program for Schizophrenia: An Intervention to Improve Pleasure and Motivation in Schizophrenia
por: Nguyen, Alexandra, et al.
Publicado: (2016)

Emotion Recognition Deficits in Psychiatric Disorders as a Target of Non-invasive Neuromodulation: A Systematic Review
por: Yamada, Yuji, et al.
Publicado: (2021)

Attention–deficit/hyperactivity disorder symptoms, perceived stress, and suicidal ideation during the COVID-19 pandemic
por: Stickley, Andrew, et al.
Publicado: (2022)

Cognitive Deficits in Schizophrenia and Other Neuropsychiatric Disorders: Convergence of Preclinical and Clinical Evidence
por: Stuchlik, Ales, et al.
Publicado: (2014)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m5ou7ar0ljajpuuq837mb7mch9